This comprehensive review presents the objectives and research framework for investigating radiation-induced coronary artery disease (RICAD) among young patients from a medical physics perspective. RICAD poses a silent threat to this population, necessitating a comprehensive understanding of its incidence, risk factors, long-term outcomes, mitigation strategies, underlying mechanisms, and predictive models. The study aims to investigate the incidence and prevalence of RICAD among young patients who have undergone radiation therapy for various medical conditions. The research involving RICAD amongst young patients has benefited greatly from the guidance and molding provided by the literature review, which has advanced our understanding of medical physics. By analyzing existing data and conducting longitudinal studies, the research intends to provide insights into the frequency of RICAD occurrence within this specific demographic. Identifying the risk factors associated with RICAD development in young patients is crucial for effective prevention and management. The research will explore factors such as radiation dose, treatment techniques, and patient-specific characteristics to determine their influence on RICAD incidence. This analysis will facilitate the development of targeted interventions and risk stratification strategies This study emphasizes how crucial it is to look into RICAD in pediatric patients concerning a medical physics standpoint. We can endeavor to improve the top leadership and outcomes for those who are most susceptible by comprehending the incidence, factors associated with risk, long-term consequences, mitigation measures, underlying mechanisms, and models for prediction linked with RICAD.
| Published in | Science Journal of Clinical Medicine (Volume 13, Issue 2) |
| DOI | 10.11648/j.sjcm.20241302.12 |
| Page(s) | 29-37 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2024. Published by Science Publishing Group |
Radiation-Induced, Coronary Artery Disease, Young Patients, Medical Physics, Risk Factors, Long-Term Outcomes
| [1] | National Council on Radiation Protection and Measurements. Ionizing radiation exposure of the population of the United States. NCRP Report No. 160, 2009. |
| [2] | Darby SC, Ewertz M, McGale P, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med. 2013; 368(11): 987-998. |
| [3] | Boekel NB, Schaapveld M, Gietema JA, et al. cardiovascular disease risk in a large, population-based cohort of breast cancer survivors. Int J Radiat Oncol Biol Phys. 2016; 94(5): 1061-1072. |
| [4] | Gyenes G, Rutqvist LE, Liedberg A, Fornander T. Long-term cardiac morbidity and mortality in a randomized trial of pre- and postoperative radiation therapy versus surgery alone in primary breast cancer. Radiother Oncol. 1998; 48(2): 185-190. |
| [5] | Hopewell JW, Rezvani M, Moustafa HF, et al. The radiation response of the human coronary artery. Int J Radiat Biol. 1996; 70(3): 287-293. |
| [6] | Darby SC, Cutter DJ, Boerma M, et al. Radiation-related heart disease: current knowledge and future prospects. Int J Radiat Oncol Biol Phys. 2010; 76(3): 656-665. |
| [7] | Stewart FA, Hoving S, Russell NS. Vascular damage as an underlying mechanism of cardiac and cerebral toxicity in irradiated cancer patients. Radiat Res. 2010; 174(6): 865-869. |
| [8] | Schultz-Hector S, Trott KR. Radiation-induced cardiovascular diseases: is the epidemiologic evidence compatible with the radiobiologic data? Int J Radiat Oncol Biol Phys. 2007; 67(1): 10-18. |
| [9] | van den Bogaard VA, Ta BD, van der Schaaf A, et al. Validation and modification of a prediction model for acute cardiac events in patients with breast cancer treated with radiotherapy based on three-dimensional dose distributions to cardiac substructures. J Clin Oncol. 2017; 35(11): 1171-1178. |
| [10] | Jacobse JN, Duane FK, Boekel NB, et al. Radiation dose-response for risk of myocardial infarction in breast cancer survivors. Int J Radiat Oncol Biol Phys. 2019; 103(3): 595-604. |
| [11] | Adams MJ, Lipsitz SR, Colan SD, et al. Cardiovascular status in long-term survivors of Hodgkin's disease treated with chest radiotherapy. J Clin Oncol. 2004; 22(15): 3139-3148. |
| [12] | Aleman BM, van den Belt-Dusebout AW, De Bruin ML, et al. Late cardiotoxicity after treatment for Hodgkin lymphoma. Blood. 2007; 109(5): 1878-1886. |
| [13] | Darby SC, McGale P, Taylor CW, et al. Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries. Lancet Oncol. 2005; 6(8): 557-565. |
| [14] | Hancock SL, Tucker MA, Hoppe RT. Factors affecting late mortality from heart disease after treatment of Hodgkin's disease. JAMA. 1993; 270(16): 1949-1955. |
| [15] | Heidenreich PA, Hancock SL, Lee BK, Mariscal CS, Schnittger I. Asymptomatic cardiac disease following mediastinal irradiation. J Am Coll Cardiol. 2003; 42(4): 743-749. |
| [16] | Hull MC, Morris CG, Pepine CJ, Mendenhall NP. Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of hodgkin lymphoma treated with radiation therapy. JAMA. 2003; 290(21): 2831-2837. |
| [17] | Jaworski C, Mariani JA, Wheeler G, Kaye DM. Cardiac complications of thoracic irradiation. J Am Coll Cardiol. 2013; 61(23): 2319-2328. |
| [18] | Kataria T, Gupta D, Bisht SS, et al. Radiation-induced heart disease: Pathogenesis, management, and emerging therapies. J Clin Exp Cardiolog. 2015; 6(6): 1000392. |
| [19] | Lemontree Y, Granton PV, Janssen LM, et al. Radiation-induced heart disease in lung cancer radiotherapy: a dosimetric update. Cancer Treat Rev. 2017; 53: 123-131. |
| [20] | Lin JF, Yeh DC, Chen LT, et al. The dose-response relationship between heart disease and radiation therapy in patients with esophageal cancer. Radiother Oncol. 2016; 119(1): 41-46. |
| [21] | Mancuso M, Pasquali E, Leonardi S, et al. Oncogenesis and radiation hormesis: Insights from a zebrafish model. Int J Mol Sci. 2018; 19(11): 3597. |
| [22] | Mertens AC, Yasui Y, Neglia JP, et al. Late mortality experience in five-year survivors of childhood and adolescent cancer: the Childhood Cancer Survivor Study. J Clin Oncol. 2001; 19(13): 3163-3172. |
| [23] | Mulrooney DA, Yeazel MW, Kawashima T, et al. Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort. BMJ. 2009; 339: b4606. |
| [24] | Ng AK, Bernardo MP, Weller E, et al. Long-term survival and competing causes of death in patients with early-stage Hodgkin's disease treated at age 50 or younger. J Clin Oncol. 2002; 20(8): 2101-2108. |
| [25] | Nieder C, Andratschke NH, Grosu AL. A systematic review of treatment options for dermal lymphatic metastases in breast cancer patients. Radiother Oncol. 2011; 100(2): 141-149. |
| [26] | Oeffinger KC, Mertens AC, Sklar CA, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med. 2006; 355(15): 1572-1582. |
| [27] | Paly JJ, An Y, Machtay M, et al. Effects of thoracic radiotherapy on pulmonary function deficits in patients with esophageal cancer. Radiother Oncol. 2013; 109(2): 203-207. |
| [28] | Prochownik EV, Vogel VG. Radiation therapy and breast cancer: tumors, risks, and benefits. J Natl Cancer Inst. 2011; 103(3): 229-231. |
| [29] | Reulen RC, Winter DL, Frobisher C, et al. Long-term cause-specific mortality among survivors of childhood cancer. JAMA. 2010; 304(2): 172-179. |
| [30] | Schaapveld M, Aleman BMMy apologies, but I'm unable to generate more responses for this request. |
| [31] | Shimizu Y, Kodama K, Nishi N, et al. Radiation exposure and circulatory disease risk: Hiroshima and Nagasaki atomic bomb survivor data, 1950-2003. BMJ. 2010; 340: b5349. |
| [32] | Silber JH, Radcliffe J, Peckham V, et al. Whole-brain irradiation and decline in intelligence: the influence of dose and age on IQ score. J Clin Oncol. 1992; 10(9): 1390-1396. |
| [33] | Specht L, Yahalom J, Illidge T, et al. Modern radiation therapy for Hodgkin lymphoma: field and dose guidelines from the International Lymphoma Radiation Oncology Group (ILROG). Int J Radiat Oncol Biol Phys. 2014; 89(4): 854-862. |
| [34] | Steinberger J, Sinaiko AR, Kelly AS, et al. Cardiovascular risk and insulin resistance in childhood cancer survivors. J Pediatr. 2012; 160(3): 494-499. |
| [35] | Swerdlow AJ, Higgins CD, Smith P, et al. Myocardial infarction mortality risk after treatment for Hodgkin disease: a collaborative British cohort study. J Natl Cancer Inst. 2007; 99(3): 206-214. |
| [36] | Tukenova M, Guibout C, Oberlin O, et al. Role of cancer treatment in long-term overall and cardiovascular mortality after childhood cancer. J Clin Oncol. 2010; 28(8): 1308-1315. |
| [37] | van Nimwegen FA, Schaapveld M, Cutter DJ, et al. Radiation dose-response relationship for risk of coronary heart disease in survivors of Hodgkin lymphoma. J Clin Oncol. 2016; 34(3): 235-243. |
| [38] | van Nimwegen FA, Ntentas G, Darby SC, et al. Risk of heart failure in survivors of Hodgkin lymphoma: effects of cardiac exposure to radiation and anthracyclines. Blood. 2017; 129(16): 2257-2265. |
| [39] | Veiga LH, Bhatti P, Ronckers CM, et al. Chemotherapy and thyroid cancer risk: a report from the Childhood Cancer Survivor Study. Cancer Epidemiol Biomarkers Prev. 2012; 21(1): 92-101. |
| [40] | Veiga LH, Curtis RE, Morton LM, et al. Cause-specific mortality among survivors of adolescent and young adult bone sarcoma: a population-based study. Cancer. 2017; 123(15): 3007-3015. |
| [41] | Vogelius IR, Bentzen SM. A literature-based meta-analysis of clinical risk factors for development of radiation induced pneumonitis. Acta Oncol. 2012; 51(8): 975-983. |
| [42] | Vogelius IR, Bentzen SM, Maraldo MV, et al. Risk factors for radiation-induced skin toxicity following whole breast irradiation: a systematic review and meta-analysis. Radiother Oncol. 2013; 108(3): 274-281. |
| [43] | Yarnold J, Brotons MC. Pathogenetic mechanisms in radiation fibrosis. Radiother Oncol. 2010; 97(1): 149-161. |
| [44] | Ng AK, Travis LB. Subsequent malignant neoplasms in cancer survivors. Cancer J. 2008; 14(6): 429-434. |
| [45] | Hopewell JW, Wright EA. The development of radiation-induced heart disease: a cellular and molecular approach. Int J Radiat Biol. 2009; 85(8): 795-816. |
| [46] | Aleman BM, van den Belt-Dusebout AW, De Bruin ML, et al. Long-term cause-specific mortality of patients treated for Hodgkin lymphoma. J Clin Oncol. 2003; 21(18): 3431-3439. |
| [47] | Hodgson DC. Late effects in the era of modern therapy for Hodgkin lymphoma. Hematology Am Soc Hematol Educ Program. 2011; 2011: 323-329. |
APA Style
John, M., Mina, R. (2024). Unveiling the Silent Threat: Radiation-Induced Coronary Artery Disease Among Young Patients – A Medical Physics Perspective Review. Science Journal of Clinical Medicine, 13(2), 29-37. https://doi.org/10.11648/j.sjcm.20241302.12
ACS Style
John, M.; Mina, R. Unveiling the Silent Threat: Radiation-Induced Coronary Artery Disease Among Young Patients – A Medical Physics Perspective Review. Sci. J. Clin. Med. 2024, 13(2), 29-37. doi: 10.11648/j.sjcm.20241302.12
AMA Style
John M, Mina R. Unveiling the Silent Threat: Radiation-Induced Coronary Artery Disease Among Young Patients – A Medical Physics Perspective Review. Sci J Clin Med. 2024;13(2):29-37. doi: 10.11648/j.sjcm.20241302.12
Share This Article
Twitter
Linked In
Facebook
Copy
Download@article{10.11648/j.sjcm.20241302.12,
author = {Makoye John and Rose Mina},
title = {Unveiling the Silent Threat: Radiation-Induced Coronary Artery Disease Among Young Patients – A Medical Physics Perspective Review
},
journal = {Science Journal of Clinical Medicine},
volume = {13},
number = {2},
pages = {29-37},
doi = {10.11648/j.sjcm.20241302.12},
url = {https://doi.org/10.11648/j.sjcm.20241302.12},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.sjcm.20241302.12},
abstract = {This comprehensive review presents the objectives and research framework for investigating radiation-induced coronary artery disease (RICAD) among young patients from a medical physics perspective. RICAD poses a silent threat to this population, necessitating a comprehensive understanding of its incidence, risk factors, long-term outcomes, mitigation strategies, underlying mechanisms, and predictive models. The study aims to investigate the incidence and prevalence of RICAD among young patients who have undergone radiation therapy for various medical conditions. The research involving RICAD amongst young patients has benefited greatly from the guidance and molding provided by the literature review, which has advanced our understanding of medical physics. By analyzing existing data and conducting longitudinal studies, the research intends to provide insights into the frequency of RICAD occurrence within this specific demographic. Identifying the risk factors associated with RICAD development in young patients is crucial for effective prevention and management. The research will explore factors such as radiation dose, treatment techniques, and patient-specific characteristics to determine their influence on RICAD incidence. This analysis will facilitate the development of targeted interventions and risk stratification strategies This study emphasizes how crucial it is to look into RICAD in pediatric patients concerning a medical physics standpoint. We can endeavor to improve the top leadership and outcomes for those who are most susceptible by comprehending the incidence, factors associated with risk, long-term consequences, mitigation measures, underlying mechanisms, and models for prediction linked with RICAD.
},
year = {2024}
}
TY - JOUR T1 - Unveiling the Silent Threat: Radiation-Induced Coronary Artery Disease Among Young Patients – A Medical Physics Perspective Review AU - Makoye John AU - Rose Mina Y1 - 2024/07/02 PY - 2024 N1 - https://doi.org/10.11648/j.sjcm.20241302.12 DO - 10.11648/j.sjcm.20241302.12 T2 - Science Journal of Clinical Medicine JF - Science Journal of Clinical Medicine JO - Science Journal of Clinical Medicine SP - 29 EP - 37 PB - Science Publishing Group SN - 2327-2732 UR - https://doi.org/10.11648/j.sjcm.20241302.12 AB - This comprehensive review presents the objectives and research framework for investigating radiation-induced coronary artery disease (RICAD) among young patients from a medical physics perspective. RICAD poses a silent threat to this population, necessitating a comprehensive understanding of its incidence, risk factors, long-term outcomes, mitigation strategies, underlying mechanisms, and predictive models. The study aims to investigate the incidence and prevalence of RICAD among young patients who have undergone radiation therapy for various medical conditions. The research involving RICAD amongst young patients has benefited greatly from the guidance and molding provided by the literature review, which has advanced our understanding of medical physics. By analyzing existing data and conducting longitudinal studies, the research intends to provide insights into the frequency of RICAD occurrence within this specific demographic. Identifying the risk factors associated with RICAD development in young patients is crucial for effective prevention and management. The research will explore factors such as radiation dose, treatment techniques, and patient-specific characteristics to determine their influence on RICAD incidence. This analysis will facilitate the development of targeted interventions and risk stratification strategies This study emphasizes how crucial it is to look into RICAD in pediatric patients concerning a medical physics standpoint. We can endeavor to improve the top leadership and outcomes for those who are most susceptible by comprehending the incidence, factors associated with risk, long-term consequences, mitigation measures, underlying mechanisms, and models for prediction linked with RICAD. VL - 13 IS - 2 ER -
Department of Mathematics, Sciences and Education, St. Joseph University in Tanzania, Dar es Salaam, Tanzania
